Plus   Neg

Jeff Bezos Sells $2.8 Bln Worth Of Amazon Shares


The world's richest man is on a stock selling spree. Amazon.com Inc.'s founder and Chief Executive Officer Jeff Bezos sold more than 500,000 shares in the e-commerce giant in the first two days of August, raising $990 million.

According to documents filed with the Securities and Exchange Commission, Bezos sold 531,852 shares over the two-day period, representing about 1 percent of Bezos' total stake in Amazon.

Bezos donated 268 shares to an unnamed non-profit organization. The shares are worth about $500,000.

Over the last week, Bezos has sold stock worth about $2.8 billion, nearly 2.5 percent of his shares in the company.

After the stock sale, Bezos now owns 57.61 million shares in Amazon and still remains the company's biggest shareholder. His former wife, Mackenzie Bezos is the company's second largest shareholder.

The reason for selling shares is not known. However, Bezos said he plans to sell stock worth about $1 billion every year to fund his space startup, Blue Origin. The company is developing a heavy-lift rocket called New Glenn, scheduled for its first launch in 2021.

In May, Mackenzie had pledged to give at least half of the $36 billion fortune, which she received after her divorce with the world's richest man, to charity.

Mackenzie signed the Giving Pledge, an initiative founded in 2010 by Bill and Melinda Gates as well as Warren Buffett that encourages the world's wealthiest people to donate more than half of their wealth to charitable causes.

Among the five richest people in America, Jeff Bezos is the only person who has not signed on the Giving Pledge initiative.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Cargill, a privately-held food and agriculture company, said Monday it will launch new private label plant-based patties and ground products in order to meet the growing global demand for protein. The new products will hit retailers and restaurants in early April. Cargill said that the plant-based protein products were developed through extensive consumer research and innovation. Taro Pharmaceuticals U.S.A., Inc., the U.S.-based business of Israeli Pharma firm Taro Pharmaceutical Industries, Ltd., recalled certain lots of seizure medication Phenytoin in the form of oral suspension for potential underdosing or overdosing, the U.S. Food and Drug Administration said in a statement. The company found that the oral suspension may not re-suspend when shaken. The Federal Trade Commission (FTC) is in the process of sending out refund checks to consumers who were allegedly misled by Office Depot, Inc. and its software provider Support.com, Inc., into buying computer repair products and services. Out of $34 million, being the total amount of checks, Office Depot paid $25 million and Support.com paid $10 million as part of 2019 settlement.
Follow RTT